| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger pseudogene 1 | 0.861 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
histone deacetylase 6 | 0.465 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
vimentin 2, pseudogene | 0.760 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | |||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | |||||||||
|
HOXA transcript antisense RNA, myeloid-specific 1 | 0.638 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
occludin | 0.507 | 0.846 | 8.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
structural maintenance of chromosomes 4 | 0.678 | 0.346 | 1.7E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome | 0.716 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
BCL2L2-PABPN1 readthrough | 0.653 | 0.500 | 0.28 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
endogenous retrovirus group K member 2 | 0.674 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
microRNA 4739 | 0.839 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
endogenous retrovirus group K member 12 | 0.678 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
endogenous retrovirus group K member 22 | 0.678 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
promoter of MAT2A antisense radiation-induced circulating long non-coding RNA | 0.792 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||
|
protein tyrosine phosphatase receptor type U | 0.581 | 0.654 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
endogenous retrovirus group K member 11 | 0.663 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
tetraspanin 3 | 0.769 | 0.192 | 6.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
cadherin 13 | 0.501 | 0.846 | 7.1E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
tripartite motif containing 28 | 0.592 | 0.731 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
tyrosine kinase non receptor 2 | 0.623 | 0.538 | 8.2E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |